Lirilumab (Anti-KIR)
A2419
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameLirilumab (Anti-KIR)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionLirilumab (Anti-KIR) is a fully human monoclonal antibody against killer-cell immunoglobulin-like receptors (KIR), with potential antineoplastic activity. Lirilumab can be used in Leukemia, squamous cell carcinoma of the head and neck (SCCHN) research. MW: 150 kD.
- Storage Instruction-20°C
- UNSPSC12352203